Mbrx stock yahoo finance

MBRX -- Is Its Stock Price A Worthy Investment? Learn More. Moleculin Biotech, Inc., a preclinical and clinical-stage pharmaceutical company, focuses on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia. The company was founded in 2015 and is based in Houston, Texas.

Through Moleculin Biotech, Inc. (“Moleculin”)(MBRX), WPD’s license partner, the WP1066 drug candidate received FDA approval for Investigational New Drug ("IND") status to be used in a Phase 1 clinical trial for the treatment of children with recurrent or refractory malignant brain tumors. MBRX interactive stock chart | Moleculin Biotech, Inc ... At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. Back. Moleculin Biotech, Inc. (MBRX) Add to watchlist. NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Moleculin Biotech, Inc. (MBRX) stock forum & discussion ... Find the latest Moleculin Biotech, Inc. (MBRX) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Moleculin Biotech, Inc. Common Stock (MBRX) After-Hours ... Moleculin Biotech, Inc. Common Stock (MBRX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.

Moleculin Biotech, Inc. Common Stock (MBRX) Stock Quotes ...

Apr 22, 2019 · According to Yahoo Finance, as of 2:44 PM, MBRX stock is trading at $2.80, which puts it up 152%. MBRX stock was up 8% in premarket trade on increased volume and was seen up as high as 158% at one point in the afternoon. Ways to Listen to the News. Moleculin Biotech (MBRX) Stock Message Board - InvestorsHub Moleculin Biotech, Inc. (Nasdaq: MBRX) to Ring The Nasdaq Stock Market Closing Bell in celebration of IPO Metabasis Therapeutics (NASDAQ:MBRX) Historical Stock Chart MBRX Stock Price and Chart — NASDAQ:MBRX — TradingView

Jul 14, 2017 · Moleculin Biotech, Inc. (MBRX) will report its next earnings on Aug 14 AMC. The company reported the earnings of $-0.12/Share in the last quarter where the estimated EPS by analysts was $-0.11/share.

MBRX interactive stock chart - Yahoo At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates … Moleculin Biotech, Inc. (MBRX) stock price ... - Yahoo Finance A look at the shareholders of Moleculin Biotech, Inc. (NASDAQ:MBRX) can tell us which group is most powerful. Insiders Moleculin (MBRX) reaches enrollment target in a clinical study evaluating its p-STAT3 inhibitor, WP1220, as a treatment for cutaneous T-cell lymphoma, a form of skin cancer Moleculin Biotech, Inc. (MBRX) stock ... - Yahoo7 Finance

Moleculin Biotech, Inc. (MBRX) Stock Price ... - Yahoo Finance

Company Name: Moleculin Biotech, Stock Symbol: MBRX, Industry: Medical https://finance.yahoo.com/news/moleculin-announces-first-patients-treated-  View live MOLECULIN BIOTECH INC chart to track its stock's price action. Find market predictions, MBRX financials and market news. finance.yahoo.com. 0.

Financial Overview - Zacks Investment Research: Stock ...

Moleculin Biotech, Inc. (MBRX) Stock Price ... - Yahoo Finance

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates  Get the annual and quarterly balance sheet of Moleculin Biotech, Inc. (MBRX)   12 Feb 2020 Here's Why We're Watching Moleculin Biotech's (NASDAQ:MBRX) Cash years after listing, if you had bought and held the shares since 1999,  View Moleculin Biotech, Inc. MBRX investment & stock information. Get the latest Moleculin Biotech, Inc. MBRX detailed stock quotes, stock data, Real-Time  Company Name: Moleculin Biotech, Stock Symbol: MBRX, Industry: Medical https://finance.yahoo.com/news/moleculin-announces-first-patients-treated-  View live MOLECULIN BIOTECH INC chart to track its stock's price action. Find market predictions, MBRX financials and market news. finance.yahoo.com. 0.